The HIV Diagnostics market size is USD 3.4 Bn in 2026.
The HIV Diagnostics market is projected to grow at a CAGR of 10% by 2033.
The HIV Diagnostics market growth drivers include rising prevalence of HIV/AIDS, increasing adoption of antibody and viral load testing, and development of advanced diagnostic technologies.
North America is a dominating region for HIV Diagnostics market.
Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, and Thermo Fisher Scientific are some leading industry players in the HIV Diagnostics market.